Amneal [AMRX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Amneal

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Amneal wins in 10 metrics, Haleon Plc - ADR wins in 9 metrics, with 0 ties. Amneal appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amneal Haleon Plc - ADR Better
P/E Ratio (TTM) 1,036.00 20.09 Haleon Plc - ADR
Price-to-Book Ratio -29.23 5.12 Amneal
Debt-to-Equity Ratio -22.94 53.41 Amneal
PEG Ratio 4.14 21.52 Amneal
EV/EBITDA 9.32 33.35 Amneal
Profit Margin (TTM) 0.12% 13.81% Haleon Plc - ADR
Operating Margin (TTM) 15.46% 22.21% Haleon Plc - ADR
EBITDA Margin (TTM) 15.46% 22.21% Haleon Plc - ADR
Return on Equity 106.73% 9.38% Amneal
Return on Assets (TTM) 6.85% 4.61% Amneal
Free Cash Flow (TTM) $220.11M $2.67B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return 20.07% -10.25% Amneal
Price-to-Sales Ratio (TTM) 1.14 3.65 Amneal
Enterprise Value $5.83B $117.43B Haleon Plc - ADR
EV/Revenue Ratio 2.04 7.95 Amneal
Gross Profit Margin (TTM) 39.51% 55.38% Haleon Plc - ADR
Revenue per Share (TTM) $9 $2 Amneal
Earnings per Share (Diluted) $0.01 $0.45 Haleon Plc - ADR
Beta (Stock Volatility) 1.18 0.23 Haleon Plc - ADR
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Amneal vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

Amneal
Haleon Plc - ADR
Amneal Stock Overview | Haleon Plc - ADR Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amneal-3.11%-1.06%4.04%23.53%38.49%32.60%
Haleon Plc - ADR-0.22%1.58%-7.49%-10.25%-6.53%-4.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amneal20.07%425.00%99.81%-30.00%-30.00%-30.00%
Haleon Plc - ADR-10.25%49.34%21.73%21.73%21.73%21.73%

News Based Sentiment: Amneal vs Haleon Plc - ADR

Amneal

News based Sentiment: POSITIVE

Amneal Pharmaceuticals experienced a highly positive month, driven by strong stock performance, positive analyst revisions, strategic debt refinancing, and progress in its product pipeline. While insider selling warrants monitoring, the overall narrative points to a company on a solid growth trajectory.

View Amneal News Sentiment Analysis

Haleon Plc - ADR

News sentiment data is not available for Haleon Plc - ADR at this time.

Performance & Financial Health Analysis: Amneal vs Haleon Plc - ADR

MetricAMRXHLN
Market Information
Market Cap i$3.25B$41.85B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,708,4209,907,060
90 Day Avg. Volume i1,696,7909,220,510
Last Close$9.97$9.02
52 Week Range$6.68 - $10.68$8.71 - $11.42
% from 52W High-6.60%-21.02%
All-Time High$24.48 (Aug 20, 2018)$11.42 (Jun 02, 2025)
% from All-Time High-59.27%-21.02%
Growth Metrics
Quarterly Revenue Growth0.03%-0.01%
Quarterly Earnings Growth2.74%0.33%
Financial Health
Profit Margin (TTM) i0.00%0.14%
Operating Margin (TTM) i0.15%0.22%
Return on Equity (TTM) i1.07%0.09%
Debt to Equity (MRQ) i-22.9453.41
Cash & Liquidity
Book Value per Share (MRQ)$-0.36$1.77
Cash per Share (MRQ)$0.24$0.08
Operating Cash Flow (TTM) i$351.08M$3.33B
Levered Free Cash Flow (TTM) i$333.75M$2.58B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Amneal vs Haleon Plc - ADR

MetricAMRXHLN
Price Ratios
P/E Ratio (TTM) i1,036.0020.09
Forward P/E i14.5921.52
PEG Ratio i4.1421.52
Price to Sales (TTM) i1.143.65
Price to Book (MRQ) i-29.235.12
Market Capitalization
Market Capitalization i$3.25B$41.85B
Enterprise Value i$5.83B$117.43B
Enterprise Value Metrics
Enterprise to Revenue i2.047.95
Enterprise to EBITDA i9.3233.35
Risk & Other Metrics
Beta i1.180.23
Book Value per Share (MRQ) i$-0.36$1.77

Financial Statements Comparison: Amneal vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AMRXHLN
Revenue/Sales i$695.42M$3.72B
Cost of Goods Sold i$439.53M$1.66B
Gross Profit i$255.89M$2.06B
Research & Development i$41.81M$105.16M
Operating Income (EBIT) i$100.92M$471.86M
EBITDA i$161.60M$488.03M
Pre-Tax Income i$37.49M$388.27M
Income Tax i$12.87M$88.98M
Net Income (Profit) i$24.62M$299.29M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AMRXHLN
Cash & Equivalents i$59.19M$911.36M
Total Current Assets i$1.51B$5.59B
Total Current Liabilities i$1.08B$6.42B
Long-Term Debt i$2.24B$10.30B
Total Shareholders Equity i$-59.39M$21.57B
Retained Earnings i$-594.87M$36.76B
Property, Plant & Equipment i$522.75M$2.52B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AMRXHLN
Operating Cash Flow i$-11.03MN/A
Capital Expenditures i$-13.60MN/A
Free Cash Flow i$-10.91MN/A
Debt Repayment i$-235.53MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAMRXHLN
Shares Short i5.05M15.71M
Short Ratio i3.321.93
Short % of Float i0.03%0.00%
Average Daily Volume (10 Day) i1,708,4209,907,060
Average Daily Volume (90 Day) i1,696,7909,220,510
Shares Outstanding i309.88M12.23B
Float Shares i168.76M8.99B
% Held by Insiders i0.46%0.00%
% Held by Institutions i0.46%0.13%

Dividend Analysis & Yield Comparison: Amneal vs Haleon Plc - ADR

MetricAMRXHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025